November 25, 2019
Researchers at Geisinger recently announced that they have developed an algorithm that uses electrocardiogram data to determine whether a person will die within a year—but they are not sure how the algorithm works.
November 22, 2019
Members of a CMS advisory panel are worried that potential long-term changes to CMS' star-ratings methodology for hospitals would not actually help consumers make informed decisions about where to go for care.
November 21, 2019
Stephen Hahn, President Trump's nominee for FDA commissioner, on Wednesday faced questions from lawmakers on the Senate Health, Education, Labor and Pensions Committee regarding drug shortages and prices, e-cigarette use, and more.
CMS on its Nursing Home Compare website has begun indicating when nursing homes have been cited for abuse violations, and while the move has been applauded by consumer advocates, some in the nursing home industry say the alerts are misleading.
Two patients with different blood diseases who were treated with CRISPR in the summer are showing significant improvements, according to new data released Tuesday.
November 20, 2019
FDA on Friday granted Pentax approval to market a duodenoscope with a sterile, disposable elevator—an innovation that reduces the number of parts that need to be cleaned and therefore could lower the odds of transmitting dangerous superbugs.
November 19, 2019
Hospitals and health insurers are criticizing the Trump administration's new rules that aim to increase price transparency in the U.S. health system—and four major hospital groups have threatened to file a lawsuit challenging the regulations.
A large, federally funded study found bypass surgeries and stents are not more effective than cholesterol-lowering drugs or healthy habits at preventing heart attacks and deaths, researchers announced Saturday at the American Heart Association's annual meeting—findings that call into question the care of thousands of patients with blocked coronary arteries.
November 18, 2019
FDA for the first time has approved an experiment that involves temporarily transplanting pig tissue into humans, a move that experts say could lead to further developments in animal-to-human donations.
As demand for in vitro fertilization has grown, fertility clinics have developed supplementary procedures, or "add-ons," that are purported to increase the odds of success—but there is little evidence these add-ons actually work.
Advisory Board. All rights reserved.